600519.SH · A-shares
600519.SH Moutai: pricing anchor in a to-C reset
Kweichow Moutai 2025 revenue ¥168.838B (−1.21%), parent NI ¥82.320B (−4.53%), first full-year double decline; H1'26 revenue ¥90.703B (+1.47%), parent NI ¥44.517B (−1.95%). 8/17 close ¥1,293 / mkt ~¥1.62T. Tape is batch price/inventory and direct-sales reform. Brief channel note; peer Wuliangye.
Cite a section with a deep link, e.g. /en/r/moutai-600519-research#thesis
Market snapshot
- A-share (8/17)
- CNY 1.29K
- Market cap (approx)
- CNY 1616.4B
- 2025 parent NI
- CNY 82.3B
- H1'26 parent NI
- CNY 44.5B
As-of 2026-09-25 (weekly refresh; equities aligned to §A. Missing series are N/A/null. Not investment advice.)
Thesis
Kweichow Moutai (600519.SH) is the pricing anchor for ultra-premium sauce-aroma baijiu. 2025 revenue ¥168.838B (−1.21%), parent NI ¥82.320B (−4.53%) — first full-year revenue and profit decline since listing; OCF ¥61.522B (−33.5%, largely finance-company optics). H1'26 revenue ¥90.703B (+1.47%), parent NI ¥44.517B (−1.95%): volumes and direct sales up, margins still mixing down.
Close 2026-08-17: ¥1,293.09, mkt ~¥1.62T (−3.64% the session after the interim). The tape no longer pays a 15% perpetual-growth multiple; it prices wholesale (batch) price / channel inventory and whether the “to-C” reform changes mix without restoring profit growth. Brief: channel & batch-price note. Peer: Wuliangye.
Business
Model: sorghum and inputs → long-aged base liquor → Moutai and series brands. Profit is brand rent plus quota; cash-before-delivery, negligible interest-bearing debt.
Flagships:
- Moutai liquor (Flying Fairy core) — 2025 ¥146.500B (+0.39%), GM 93.53%; ~46.8kt (+0.73%), ~¥1,565/500ml ASP equivalent.
- Series liquor — 2025 ¥22.275B (−9.76%), GM 76.11%; the annual report cites series mix as the main drag on group revenue.
- iMoutai / direct — full-line listing in 2026; H1'26 ¥40.264B (+274%), the to-C volume amplifier.
Edge: (1) ritual/gifting brand that still sets the sector’s batch-price mood; (2) cellar-aged base liquor and “no new wine” craft as supply rigidity.
Strategy (12–24m): dropped the old ~15% revenue growth target; pyramid SKUs, floating retail prices, self-sell + dealers + consignment. Near-term: direct mix supports volume, but H1'26 COGS +21.8% and GM down — reform has not yet shown up as profit growth.
Strategy pillars
| Pillar | Detail |
|---|---|
| 主业定位 | 酱香白酒定价锚；飞天为塔基，精品/生肖为塔腰，陈年/文化为塔尖 |
| 产量 / 投放 | 2025 茅台酒销量约 4.68 万吨（+0.73%）；2026H1 茅台酒/系列酒基酒产量约 4.1 / 3.1 万吨 |
| 价格机制 | 合同价 1169→1269（2026-03）→1369（2026-07）；自营零售随行就市，批价仍是情绪锚 |
| 渠道向 C | 自售+经销+代售；i 茅台上架飞天/全系，2026H1 i 茅台收入 402.64 亿（+274%） |
| 股东回报 | 承诺分红不低于当年归母 75%；2025 年报拟每股 27.993 元（约 350.33 亿） |
Entity boundary: Kweichow Moutai Co., Ltd. (600519.SH); parent is the unlisted Moutai Group. Do not conflate with group tourism/health-liquor vehicles. No liquidation/resumption-type actions in-period.
Value chain
Position: midstream branded distiller at the highest surplus in the chain — brand rent, not grain crushing.
| Side | Counterparties | Dependence |
|---|---|---|
| Upstream | Hongyingzi sorghum (co-ops/farmers), packaging, energy, pits | Origin and craft locked; series capex is the medium-term supply lever |
| Downstream | Distributors, owned stores, iMoutai, KA/e-commerce, banquet/gifting | Demand tied to business and gifting; batch price forms in wholesale |
Customer structure
| Item | Value | Note |
|---|---|---|
| 客户类型 | 社会经销商 + 自营/i 茅台 C 端 + 商超/电商 | 批发代理与直销 2025 年约各半 |
| 前五大客户 | 10.10%（170.46 亿） | 2025 年报；关联方占比较低 |
| 直销占比 | 2025 年 845.43 亿（+13.0%）；2026H1 520.07 亿 / 57% | 直销毛利率更高，但费用与 ASP 结构变化 |
| 经销商数量 | 国内 2307 / 国外 119（2026H1 末） | 系列酒经销商进出为主；先款后货为主 |
| 地域 | 国内约 97%；国外 2025 年 48.5 亿（−6.5%） | 海外非利润核心 |
Concentration: 2025 top-5 customers ¥17.046B, 10.10% of sales (unnamed). Cash-before-delivery; ~97% domestic.
Supply risks: (1) sorghum/packaging origin and related-party supply; (2) cellar age so capacity cannot convert to sales in-year — echoed in risks.
Corporate events
24–36m: to-C channel rewrite, asymmetric list-price hikes, SASAC chair change, plus the first annual double decline.
Corporate events
| Date | Phase | Event | Meaning |
|---|---|---|---|
| 2025-10/11 | 人事 | 张德芹辞任董事长；陈华接任集团/股份董事长 | 国资任命，经营连续性观察期 |
| 2026-01 | 渠道 | i 茅台上架 500ml 53° 飞天并扩展全系 | 直销权重跃升，批价/配额体系重构 |
| 2026-03-31 | 价格 | 飞天合同价 1169→1269；自营零售 1499→1539 | 非对称提价；官方价向市场靠拢 |
| 2026-04-16 | 财报 | 2025 年报：营收 1688.38 亿（−1.21%）、归母 823.20 亿（−4.53%） | 上市以来首次全年营收净利双降 |
| 2026-06 | 人事 | 王莉代行总经理；余思明任财务总监兼董秘 | 经营层过渡，非控制权变更 |
| 2026-07 | 价格 | 合同价再调至 1369；i 茅台/自营零售继续上调 | 量价再平衡，批价能否跟上是关键 |
| 2026-08-14 | 财报 | 2026 中报：营收 907.03 亿（+1.47%）、归母 445.17 亿（−1.95%） | 增收不增利；次日股价大跌 |
Valuation
A-share ¥1,293.09 on 2026-08-17, mkt ~¥1.62T. Trailing P/E ~19.6x, P/B ~6.6x. The market is paying “reform pain + soft batch price,” not a 30x growth sticker.
Contract price: 2026-03-31 Flying Fairy ¥1,169→¥1,269; July ¥1,369; iMoutai/owned retail moved with it. Spring 2026 wholesale prints ~¥1,655 cased / ¥1,565 loose (third-party, noisy) — batch still below some owned-retail tags, squeezing dealer economics.
Valuation snapshot (multi-lens)
| Metric | Value | Note |
|---|---|---|
| 现价 / 市值 | 1293.09 元 / 约 1.62 万亿 | 2026-08-17 收盘；一日蒸发约 611 亿 |
| TTM P/E | 约 19.5–20x | 市值 / 2025 归母 823.20 亿 ≈ 19.6x |
| P/B | 约 6.6x | 2025 末归母净资产 2446.38 亿 |
| 盈利收益率 | 约 5.1% | 1/PE；仍高于十年期国债但低于历史茅台溢价期 |
| 股息率 | 年报拟派约 2.2%；累计分红口径约 4% | 每股 27.993 元 / 1293；2025 年度累计分红 650.33 亿 |
| 现价读法 | 市场在定价渠道改革阵痛 + 批价不强 | 不再给 15% 增长永续溢价 |
~3y multiples and trailing returns (illustrative public tape):
Valuation & returns · ~3y
Interactive chart available in the reader.
Share price · ~3y
Interactive chart available in the reader.
Financial trend (~24 months)
Eight quarters of revenue and GM with YoY / QoQ. Seasonality: Q1 CNY peak, Q2 sequential drop is normal; 2025Q4 revenue −19.4% YoY was the double-decline stamp; 2026Q2 ¥36.79B (−5.1% YoY) stayed soft after the peak.
Revenue · last 8 quarters
Interactive chart available in the reader.
Gross margin · last 8 quarters
Interactive chart available in the reader.
Quarterly GM interpolated from FY/H1 blended GM (~91.9% / ~91.2% / ~89.6%); H1 COGS +21.8% tracks mix.
Financial health
Fortress net cash. Ignore headline OCF YoY swings driven by the finance subsidiary.
Financial health (OCF / debt / liquidity / audit)
| Item | Value | Note |
|---|---|---|
| 财务健康总评 | 极强净现金 | 几乎无有息债；利润率仍处白酒巅峰，但 2026H1 毛利率受结构拖累 |
| 经营现金流 | 2025 年 615.22 亿（−33.5%）；2026H1 706.91 亿（+439%） | 波动主因财务公司存款口径，非主业失血 |
| 货币资金 / 现金类 | 2026H1 末货币资金 535.19 亿；新闻口径现金余额约 1848 亿 | 含财务公司拆放等同业；较年初 +46%（新闻口径） |
| 有息债 vs 现金 | 净现金（有息债可忽略） | 财务费用持续为负 |
| 流动性 | 经销商预收款 + 先款后货 | 渠道改革期关注预收款下降是否等于动销 |
| 审计 / 持续经营 | 天健所 2025 年标准无保留 | 2026 中报未经审计；无持续经营强调 |
Net income · last 8Q
Interactive chart available in the reader.
Operations
Volume: 2025 liquor sales 85.1kt (+2.1%), Moutai brand ~46.8kt; H1'26 base-liquor output ~41kt / 31kt (Moutai / series). Price: list hikes vs soft batch — ASP is not one-way up. Cost: direct mix lifts some opex/COGS.
Segments / mix
| Segment | Scale / mix | Watchpoint |
|---|---|---|
| 茅台酒 | 2025 年 1465.00 亿（+0.39%），毛利率 93.53% | 销量约 4.68 万吨；吨价/瓶价仍是核心 |
| 系列酒 | 2025 年 222.75 亿（−9.76%），毛利率 76.11% | 年报称营收下滑主因系列酒结构调整 |
| i 茅台 | 2026H1 402.64 亿（+274%），约占营业总收入 44% | 直销放大器；ASP 与费用结构与批发不同 |
| 直销 vs 批发 | 2025 直销 845.43 亿 / 批发 842.32 亿；2026H1 直销 57% | 直销毛利率更高，但批发仍是批价形成机制 |
Competition
Peers: Wuliangye, Luzhou Laojiao 000568, Fenjiu 600809.
Strengths: irreplaceable ultra-premium sauce-aroma; net cash and payout; speed of iMoutai to-C. Weaknesses: gifting/banquet-heavy demand; batch-price trading tape; profit growth lagging revenue in the direct-sales transition.
Punchline: still the anchor on share of mind; 2025–26 is a defend-price / destock year, not a raise-and-grow year.
Peer comparison
| Company | Position / share | Gross margin | Strength | Weakness |
|---|---|---|---|---|
| 贵州茅台 600519 | 超高端酱香定价锚 | 酒类 91.2%（2025） | 品牌/配额/净现金；直营数字化 | 批价与渠道库存敏感；增长目标取消 |
| 五粮液 000858 | 高端浓香第二极 | 酒类 83.8%（2025 重述） | 第八代大单品；渠道深度 | 收入确认重述 + 董事长留置；信任折价 |
| 泸州老窖 000568 | 高端浓香第三极 | 高（次于茅五） | 国窖 1573 价格带 | 高端需求收缩时弹性大于茅台 |
| 山西汾酒 600809 | 清香次高端放量 | 低于超高端 | 玻汾/青花放量 | 价格带下移竞争更烈 |
Management
Key management (24m)
| Role | Name | Since | 24m change |
|---|---|---|---|
| 董事长 | 陈华 | 2025-11 | 接替张德芹（2025-10 因工作调整辞职） |
| 总经理（代行） | 王莉 | 2026-06 代行 | 代行总经理职责；同时任集团总经理 |
| 财务总监 / 董秘 | 余思明 | 2026-06 | 新聘财务总监兼董事会秘书 |
24m changes: Oct 2025 Zhang Deqin resigned as chair (job reassignment); Chen Hua (ex-Guizhou Energy Administration) took over. Jun 2026 Wang Li acting GM; Yu Siming CFO/board secretary. SASAC appointment transition, not a change of control.
Stability: medium transition risk — “to-C” is consistent in filings, but dealer relationships under a new chair need 2–4 quarters.
Outlook
Near-term: sell-side FY26 parent NI has been cut from ~¥87B toward ¥83–86B (street, not company guidance). The 2025 annual report did not reset a high growth target.
Medium-term: batch vs contract, weeks of inventory, whether iMoutai is incremental openings or just wholesale diversion. Consumption scenes still weaker than the 2021–23 business peak.
Scenarios
| Scenario | Conditions | Implication |
|---|---|---|
| Bull | Batch holds, openings recover, direct opex falls | Profit back to LSD growth; multiple 22–25x |
| Base | LSD revenue, flat-to-down profit, dividend floor | ¥1,200–1,500 range; own as yield/defense |
| Bear | Batch below contract, restocking, reform stall | Multiple ~15x, sector-risk-off |
Risks
Risks (with severity)
| Risk | Level | Note |
|---|---|---|
| 批价失守 / 渠道库存 | 高 | 飞天一批价是交易情绪核心；库存周数拉长会压制提价效果 |
| 直营改革阵痛（增收不增利） | 高 | 2026H1 归母 −1.95%；毛利率随结构下移 |
| 商务/宴席需求弱于预期 | 中高 | 白酒周期与宏观消费场景绑定 |
| 管理层过渡与国资任命 | 中 | 董事长更替来自省管干部调整，执行连贯性待观察 |
| 高粱/包装/产能约束 | 中 | 上游红缨子高粱与基酒窖龄；系列酒技改节奏 |
| 财务公司口径扰动 OCF | 低 | OCF 同比大起大落不一定等于主业现金流 |
Tracking
- Flying Fairy batch (cased/loose) vs contract and owned retail
- Channel weeks of inventory and dealer prepayments
- Next-print Moutai brand volume/ASP and series stabilization
- iMoutai mix and direct GM
- FY26 parent NI vs the ~¥83–86B street band
Confirm: batch stable and GM stops stepping down. Falsify: batch stays below ex-factory/contract and dealers are force-fed.
References
- Kweichow Moutai 2025 annual report — https://www.moutaichina.com/mtgf/articleFileDir/2026-04/17/1b9fae59825c41bf9a776892a00565f7.pdf
- 2026 interim report — http://static.cninfo.com.cn/finalpage/2026-08-15/1225475868.PDF
- 2026 Q1 report — http://static.cninfo.com.cn/finalpage/2026-04-25/1225187851.PDF
- CNINFO 600519 — https://www.cninfo.com.cn/new/disclosure/stock?stockCode=600519&orgId=gssh0600519
- batch-price brief · Wuliangye
Not investment advice. Batch prices are third-party and noisy; valuation series are illustrative — filings and terminals prevail.
Comments
Sign in to comment